Protective and regenerative effects of a novel medical device against esophageal mucosal damage using in vitro and ex vivo models

• Published in: Biomedicine & pharmacotherapy 2020-11, Vol.131, p.110752-110752, Article 110752
• Main Authors: Agostinis, Chiara, Bossi, Fleur, Mangogna, Alessandro, Balduit, Andrea, Pacor, Micol, Giacomello, Emiliana, Belmonte, Beatrice, Greco, Daniele, Rodolico, Vito, Voinovich, Dario, De Seta, Francesco, Ricci, Giuseppe, Bulla, Roberta
• Format: Article
• Language: English
• Subjects: Adhesiveness; Amino Acids - administration & dosage; Amino Acids - chemistry; Bioadhesive polymer; Cell Line, Tumor; Equipment and Supplies; Esophageal Mucosa - drug effects; Esophageal Mucosa - physiology; Gastroesophageal Reflux - drug therapy; Gastroesophageal reflux disease (GERD); Humans; Hyaluronic acid; Hyaluronic Acid - administration & dosage; Hyaluronic Acid - chemistry; Medical device; Oryza; Permeability; Plant Extracts - administration & dosage; Plant Extracts - chemistry; Regeneration - drug effects; Regeneration - physiology; Rice extract
• ISSN: 0753-3322; 1950-6007
• DOI: 10.1016/j.biopha.2020.110752

[Display omitted] Gastroesophageal reflux disease (GERD) is a common digestive disorder that causes esophagitis and injuries to the esophageal mucosa. GERD symptoms are recurrent during pregnancy and their treatment is focused on lifestyle changes and nonprescription medicines. The aim of this study was to characterize the mechanism of action of a new patented medical device, an oral formulation containing hyaluronic acid, rice extract, and amino acids dispersed in a bioadhesive polymer matrix, by assessing its protective effects in in vitro and ex vivo models of esophageal mucosa damage. Acidic bile salts and pepsin cocktail (BSC) added to CP-A and COLO-680 N esophagus cells were used as an in vitro GERD model to evaluate the binding capacities, anti-inflammatory effects and reparative properties of the investigational product (IP) in comparison to a viscous control. Our results showed that the IP prevents cell permeability and tight junction dysfunction induced by BSC. Furthermore, the IP was also able to down-regulate IL-6 and IL-8 mRNA expression induced by BSC stimulation and to promote tissue repair and wound healing. The results were confirmed by ex vivo experiments in excised rat esophagi through the quantification of Evans Blue permeability assay. These experiments provided evidence that the IP is able to bind to the human esophagus cells, preventing the damage caused by gastroesophageal reflux, showing potential anti-irritative, soothing, and reparative properties.